|
Mutation Information
|
Mutation Site
|
M230L |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
Literature Information
|
PubMed PMID
|
32974670
|
|
Published Year
|
2021 |
|
Journal
|
The Journal of antimicrobial chemotherapy |
|
Title
|
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations. |
|
Author
|
Saladini F,Giammarino F,Hosseini BA,Giannini A,Boccuto A,Dragoni F,Vicenti I,Shafer RW,Zazzi M |
|
Evidence
|
METHODS: In vitro phenotypic susceptibility to doravirine was assessed in 10 clinically derived infectious clones with intermediate- to high-level resistance to rilpivirine, etravirine, efavirenz and nevirapine, and in NL4-3 site-directed mutants harbouring K103N, Y181C, M230L or K103N/Y181C NNRTI mutations.
|
|
|
HIV Mutation Detail Information